Evidence map›Paper›PMID 29955077›Full record

ArticleScientific reports2018

Inflammatory cytokines and biofilm production sustain Staphylococcus aureus outgrowth and persistence: a pivotal interplay in the pathogenesis of Atopic Dermatitis.

E G Di Domenico, I Cavallo, V Bordignon, G Prignano, I Sperduti, A Gurtner, E Trento, L Toma, F Pimpinelli, B Capitanio and 1 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07259343 (Effect of Glycomacropeptide on Clinical Manifestations of Atopic Dermatitis in Children), which is not on this map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07259343 narecruitingnot on this mapstarted 2025, after this paper: background citation

Effect of Glycomacropeptide on Clinical Manifestations of Atopic Dermatitis in Children: a Pilot Study

TypeinterventionalSponsorUniversidad Autónoma de AguascalientesRan2025 to 2026Enrolled20ConditionsAtopic Dermatitis (AD)Armsglycomacropeptide, emollient cream
3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Pharmaceutics · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Life (Basel, Switzerland) · 2025
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Biofilm · 2024
    Article
  14. Article
  15. Adding Fuel to the Fire? The Skin Microbiome in Atopic Dermatitis.The Journal of investigative dermatology · 2024
    Review
  16. Article
  17. Investigating genomic diversity ofFrontiers in microbiology · 2024
    Article
  18. Evaluation of the Efficacy of Xyloglucan, Pea Protein andInternational journal of molecular sciences · 2023
    Article
  19. Atopic dermatitis-derivedFrontiers in cellular and infection microbiology · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

E G Di DomenicoClinical Pathology and Microbiology, San Gallicano Institute, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00144, Rome, Italy. enea.didomenico@ifo.gov.it.ORCID 0000-0001-6295-6006
I CavalloClinical Pathology and Microbiology, San Gallicano Institute, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00144, Rome, Italy.
V BordignonClinical Pathology and Microbiology, San Gallicano Institute, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00144, Rome, Italy.
G PrignanoClinical Pathology and Microbiology, San Gallicano Institute, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00144, Rome, Italy.
I SperdutiBiostatistics, San Gallicano Institute, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
A GurtnerDepartment of Research, Advanced Diagnostics, and Technological Innovation, Translational Research Area, Regina Elena National Cancer Institute, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00144, Rome, Italy.ORCID 0000-0002-7661-9059
E TrentoClinical Pathology and Microbiology, San Gallicano Institute, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00144, Rome, Italy.
L TomaInfectious Disease Consultant, Regina Elena National Cancer Institute, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00144, Rome, Italy.
F PimpinelliClinical Pathology and Microbiology, San Gallicano Institute, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00144, Rome, Italy.
B CapitanioDivision of Dermatology, San Gallicano Institute, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00144, Rome, Italy.
F EnsoliClinical Pathology and Microbiology, San Gallicano Institute, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00144, Rome, Italy.
Istituti di Ricovero e Cura a Carattere Scientifico · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Individuals with Atopic dermatitis (AD) are highly susceptible to Staphylococcus aureus colonization. However, the mechanisms driving this process as well as the impact of S. aureus in AD pathogenesis are still incompletely understood. In this study, we analysed the role of biofilm in sustaining S. aureus chronic persistence and its impact on AD severity. Further we explored whether key inflammatory cytokines overexpressed in AD might provide a selective advantage to S. aureus. Results show that the strength of biofilm production by S. aureus correlated with the severity of the skin lesion, being significantly higher (P < 0.01) in patients with a more severe form of the disease as compared to those individuals with mild AD. Additionally, interleukin (IL)-β and interferon γ (IFN-γ), but not interleukin (IL)-6, induced a concentration-dependent increase of S. aureus growth. This effect was not observed with coagulase-negative staphylococci isolated from the skin of AD patients. These findings indicate that inflammatory cytokines such as IL1-β and IFN-γ, can selectively promote S. aureus outgrowth, thus subverting the composition of the healthy skin microbiome. Moreover, biofilm production by S. aureus plays a relevant role in further supporting chronic colonization and disease severity, while providing an increased tolerance to antimicrobials.

Indexed as

Anti-Infective AgentsBiofilmsChildChild, PreschoolCoagulaseCytokinesDermatitis, AtopicDrug Resistance, BacterialFemaleHumansInfantInflammation MediatorsMaleMicrobial Sensitivity TestsOxacillinSeverity of Illness IndexAnti-Infective AgentsCoagulaseCytokinesInflammation MediatorsOxacillin

Identifiers

PMID29955077
PMCPMC6023932
OpenAlexW2809010410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.